MALIGNANT HISTIOCYTOSIS RESISTANT TO ANTHRACYCLINE - RESPONSE TO INTENSIVE TREATMENT WITH ETOPOSIDE AND AMSACRINE

被引：6

作者：

ABRAMS, RA ^{[1
]}

HANSON, G ^{[1
]}

HANSEN, R ^{[1
]}

BAUMANN, MA ^{[1
]}

ANDERSON, T ^{[1
]}

机构：

[1] MED COLL WISCONSIN, DEPT PATHOL, MILWAUKEE, WI 53226 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 1985年 / 145卷 / 04期

关键词：

D O I：

10.1001/archinte.145.4.742

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：742 / 743

页数：2

共 10 条

[1]

ABRUSO DR, 1980, CANCER, V45, P2516

[2]

ALEXANDER M, 1977, CANCER-AM CANCER SOC, V39, P1011, DOI 10.1002/1097-0142(197703)39:3<1011::AID-CNCR2820390303>3.0.CO

[3]

2-A

[4] THE HISTIOCYTIC DISORDERS - A PATHOPHYSIOLOGIC ANALYSIS [J].

GROOPMAN, JE ;

GOLDE, DW .

ANNALS OF INTERNAL MEDICINE, 1981, 94 (01) :95-107

[5] 4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE (AMSA) - A NEW DRUG EFFECTIVE IN THE TREATMENT OF ADULT ACUTE-LEUKEMIA [J].

LEGHA, SS ;

KEATING, MJ ;

ZANDER, AR ;

MCCREDIE, KB ;

BODEY, GP ;

FREIREICH, EJ .

ANNALS OF INTERNAL MEDICINE, 1980, 93 (01) :17-21

[6]

RADICE PA, 1979, CANCER TREAT REP, V63, P1231

[7]

SINKOVICS JG, 1979, MED ONCOLOGY ADV COU, P79

[8]

STEIN RS, 1976, CANCER, V38, P1083, DOI 10.1002/1097-0142(197609)38:3<1083::AID-CNCR2820380307>3.0.CO

[9]

2-B

[10]

TSENG A, 1983, P AN M AM SOC CLIN, V2, P210

← 1 →